20 early-stage treated PD patients, and 20 controls. In all cases, the PD related olfactory dysfunction was bilateral and no difference was observed between the test scores of patients taking or not taking drugs for PD. Although asymmetries of unsystematic direction were present in the test scores of some PD patients, similar asymmetries were observed In the controls and the asymmetries were not related to the side oftbe major motor dysfunction.
As In earlier work, no relation was present between the olfactory test scores and the degree of tremor, rigidity, bradykinesia, or gait disturbance at the time of testing. These findings Indicate that the olfactory dysfunctIon of early stage PD Is robust, typically of the same general magnitude on both sides of the nose, and uninfluenced by antl-Parklnsonian medications.
Decreased ability to smell is present in patients with early-stage Alzheimer's disease,'-' idiopathic Parkinson's disease (PD).~'O and the Parkinsonism-dementia complex of Guam (PDC)." Although the physiological basis of thcsc dccrements is poorly understood. both periphcral and central segments of the olfactory pathways secm to be affected. For example. degenerative changes have been noted in the olfactory epithelium. the olfactory bulb. and the pyriform. prepyriform.
and entorhinal cortices of patients with Alzheimcr's disease.'2-" Although fcw studies of the neuropathology of the olfactory pathways of PD patients are available, near-total loss of cells within the anterior olfactory nucleus has been de$cribed for PDC.R ecent studies suggest that the olfactory dysfunction of idiopathic PD does not progress .;ignificanlly o\'er timl.' and i.; unrl'laled to Corr~,pond~n~~ 10-Dr 0.,1.., Dir«1or, Smtll and T~.I~ Ccnl~r, S R~ydin In,lilul~, H."pilal of Iht Vni\-~rsily of P~nnsylyania, ).100 Spruc~ Slr«l, Phil~d~lphla, PA 19J04 (21S-!l62-6S8O) R\"<~i\<.J ~S F~bru~ry 1991 nd in r.:\i~d f.,rm R July IOQI A",-r',-J 17 Jul\ 1""1 the degree of motor and cognitive symptoms (implying independence from the more dynamic elements of the disease proper).' , Quantilalive testing of only four untreated PO patients, however, has been reported in Ihe literature,"
and whether the olfactory loss is symmetric or asymmetric is unknown as only bilateral testing has been performed (such testing largely reflects the best functioning nasal chamber).ll Given that the olfactory projections have a very large ipsilateral component (possibly explaining why unilateral temporal lobe resection impairs odour identification ability in Ihe nostril ipsilateral to the resected 10be),12 the presence of olfactory asymmetry might provide a marker for hemispheric differences in neurotransmitter function. Functional or anatomical asymmetries of dopaminergic systems have been suggested, on the basis of both neuropsychological and neurochemical findings, to be present in the central nervous system (CNS) of PO patients, although the differences are often subtle.»:4
We studied whether the olfactory disorder of early-stage PO was asymmetric and, if so, whether the asymmetry was correlated with that observed in the motor system. We also compared the olfactory function of early-stage patients taking anti-Parkinsoniiln medications to that of early-stage patients not taking such medications.
Materials and methods
Suhjtc,s The untreated study group comprised of 20 patients with early PO who were enrolled in the OA T A TOP clinical trial.» All of them had never taken or had stopped taking anti-Parkinsonian medications for a period of at least six weeks before olfactory testing. Five were left handed and the remainder right handed: Twenty patients with PO not enrolled in OA T A TOP who were taking anti-Parkinsonian medications at the time of the study made up the medicated study group, whereas 20 individuals without neurological disease served as normal controls. One of the medicated PO patients was left handed; all of the others and the control subjects were right handed. The three groups were selected to contain patients of similar age, sex, and smoking habits, since these factors are known to influence the olfactory measure used in this study. ~~ Within the gr(lur taking antiparkin$Mian drugs. I Q \\"ere ti&htly scal~ ~'ith a piece or Microroam TM ta( 3M Corporation, Minncapolis, MN) fitted to thc perimctcr of the naris. The tape insured that nasal inhalation occurred only on one side of the nose and prccluded active retronasal movement of air to thc rcccpton or the contralatcral nasal chamber. I) The testing ordcr of thc nares and the prescntation ordcr or the UPSIT booklets was counterbalanced across subjects. ( 'ymploml (yclr,) .~~In (SO, """hn In.l Yahr 'tal~t aking Sincmet (I-dopa with carbidopa), either alone (eight patients) or in combination with anticholincrgic drugs (such as benztropine) or other dopamine-related drugs {such as amantadin, bromocriptine) or both (II patients). One patient was taking an anticholinergic drug alone {ethopropazine).
The two groups of patients were statistically comparable in terms of age, g~nder, and smoking habits (table I). The duration of the dis~ase, how~ver, was much shorter in the untreated than in the treated pati~nts (group x g~nder analysis of covarianc~ (ANCOV A) Group F ( 1,35) = 30'93, p < 0-001; covariate = age).~ The mean age of the control group was higher than that of the untr~at~d PO group (t = 3-60, df = 19, p = 0-034), largely because four controls could not be placed within a five year age bracket to their respective PO matches. These diff~rences w~re of no consequence to the findings of the study, as there was no association between dis~ase duration and the magnitude of the olfactory dysfunction {in concurrence with earlier work);' the direction ofth~ ag~ difference would mitigate against the hypothesis of a PD relat~d d~ficit in olfactory functionZ1 )1 (which, in fact, was found); and age was used as a covariate in most of the statistical analyses.
Olfactory ttst proctdurt The Univ~rsity of Pennsylvania Sm~1l Id~n-tification Test (UPSIT),H a standardis~d forced choic~ test {comrn~rcially availabl~ as the Smell Id~ntification Test TN, S~nsonics, Inc. Haddonfield, NJ) was chos~n because of its ease of administration.
strong correlations with more tim~ consuming test m~asures (for ~xample, olfactory thresholds), and high reliability.H 12
The details of this test are presented elsewh~re.360-2t )1 )2 Briefly, each of the 40 pag~s of this four booklet t~st contain a microencapsulat~d (.'scratch and sniff") odour and a related four alternative multipl~ choic~ qu~stion. The subj~ct.s task is to provide on~ of the four indicat~d answers. ~v~n ifno sm~1l is perceived {that is, th~ t~st is forc~d choice). Th~ stimuli of this t~st span a wide rang~ of qualitative odour classes, consist of both singl~ and multiplc omponent odorants. and are familiar and r~adily identifiable by most people within the context of a multiple-choice response format.H Two booklets (20 odours) of the UPSIT were administ~red to each nasal chamber of the test subjects by a trained test administrator who r~leased the stimuli under each subject's nose, read aloud the response alternatives, and recorded the responses" The nostril contralateral to thc onc bcing tcstcd ""as c"mf"rtably but Assessmml 0/ cognititle/unction All of the PD patients were given the 40 item Picture Identification Test (PIT), a forced choice visual test identical to the UPSIT except that line drawings, rather than odours. are used as stimulus items.)4 This test is specifically designed to screen for patients whose aberrant UPSIT scor~s might be due to problems in comprehending non-olfactory components of the test rather than to problems in olfactory perception. The PIT correlates well with a number of neuropsychological measures and is sensitive to dementia-related cognitive deficits. as described elsewhere.' 
Results
Relative to nonnal controls, both the treated and untreated PD patients showed decreased olfactory function on both sides of the nose (table 2) . Because several PD patients had severe olfactory dysfunction, data are presented separately in table 2 for those patients whose total UPSIT score (L + R) was greater than 20 to establish whether systematic decreases in the test scores for one or the other side of the nose might be confined to cases with a better sense of smell. No significant left:right differences in the test scores were found (regardless of disease stage or level of olfactory functioning), and the test scores were unrelated to the side of PD-r~lated motor disturbance and not significantly influenced by th~ use of anti-Parkinsonian drugs (all p values > 0.10). No consist~nt r~lation was observ~d between the subjects' handedness and the asymmetry in the average test measures (for ~xample, for right handed subjects the mean (SD) left and right UPSIT SCQres \\-ere 11-03 (4-40) and 10.56 (4-)8); analogous scores for I~ft-handers )2.67 (3.98) and ))-33 (4-)3», although the small number of left hand~d subjects (six) precluded a definitive statistical test of this issue-As ~xpect~d, however, on the basis of pr~vious studies" the PD patients exhibited clear olfactory dysfunction not attributable to non-olfaclor~. rclalcd cognilivc probll'ms (lhat T 4lbl, 1 MtGn ( SDJ UnitltrJlty ,,1l'tnlUy/t'cI";" S",tlllJ("rifi(G/;QfI TtU ( UPS1T) ...ort.l"r lm'rtGltd "nd I,t",td p"lit"'1 WI"' PGr*'.nlOl1;.1n ""J normal (D"'r0/.. DDln;l1al11 Jldt ;. -ior 6CIdy .;dt 01 pri,"a". PD-rtl""d lOk1'or 'Y"'P'°'"'. Ea," "a.al (""",htr WII'lt"tJ (&,j", 10 Ul'SIT ;,t"" (rolal,.,..i6l, ',orl ZOI U..,rt..,tJ ~"/.."
T,,-,,4' ,.tW"" N..,""" ,""Dl. 'n -20; "n -19; 'n -12; .n -13; .n -10; 'D 2 9; 'a -6; "n -S. .Indiatn conlrols di".~~ si&nificanlly (rom each 0( lhc PD &roupt (p v.lun < 0.001; sec text). which did not di".~r (rom onĨ notber .An.lo&oUS IcstS bctw~~n untr~.t~d and tr~.led &roUpS w~r~ nOI sicnificant in Iny subiKt at~&ory (p vllua > 0.10).
is, all but five scored 40/40 on the PIT; the remainder missed three or fewer items). Thus, the left and right side UPSIT scores of the controls were significantly higher than the left and right side UPSIT scores of the two patient groups (group x gender ANCOV A; covariate = age; group Fs(I,S5) = 7-69&9-SI,pvalues = 0-008 and 0-003), which in no case differed significantly from one another (post hoc comparison p values > 0-20). Women, on average, obtained higher UPSIT scores than men, regardless of the side of nose tested (left and right UPSIT gender Fs (I,SS) = S-SS and 3-86, p values = 0-022 and 0-OS4; mean (SO) left and right UPSIT scores for male and female PO patients and the male and female normal cdntrols, respectively: 10-23 (4-03), 10-00 (4-!6), 13-78 (4-3S), 13.22 (4-68), 16-33 (2-09), 15-73 (3.28) , 17-00 (3-00), and 17-60 (1-9S». Analogous ANCOV As between the untreated and treated PO groups yielded no significant group F values in any subject category (p > 0.10), although in most cases significant gender effects were observed (p values < 0-05).
Most of the PO patients showed UPSIT scores on each side of the nose that were equivalent or relatively close to one another. Thus, IS8f. had equivalent scores on each side of the nose, 308f. had scores differing by one UPSIT point, arid 208f. had scores differing by two UPSIT points. Scores differing by three, four, five and six UPSIT points were noted in the remaining 12-S%, 12-S8f., S.I., and So/. of the PO subjects, respectively-For the study group as a whole these differences were, on average, symmetrical (median (interquartile range) asymmetry value = 0 ( -1 to + 2-S), where negative numbers indicate larger right side values and positive numbers larger left side values). This average lack of asymmetry was also observed for the normal subj~cts where the median asymm~try value also was equal to 0 ( -3 to + 2-S). No meaningful associations were observed between the direction of the asymmetries in the PO patients and the side of the major PO symptoms, even in those subjects who evidenced the largest apparent olfactory asymmetries.
Few of the correlations computed among the variables (for example, gender. age. smoking status. Hoehn and Yahr stage. neurological ratings) for the PD groups combined were significant at p = 0.05 (Bonferroni's correction for inflated alpha).'. Nevertheless. significant correlations were observed among the various olfactory measures (for example. left UPSIT tI right UPSIT r = 0-81; dominant side UPSIT tI nondominant side UPSIT r = 0-80) and among several neurological measures (for example. disease duration v right rigidity r = 0'48; gait II bradykinesia = 0-57; left rigidity tI left tremor r = 0-60). The pattern of associations between the variables was similar to that observed in earlier studies.' 1 as shown by factor loadings extracted with a principal components factor analysis with a varimu. rotation.-Because of this similarity. the details of the factor analysis are not presented here.
As in our earlier work.' each patient was asked whether he or she suffered from any smell or taste problems before olfactory testing. Four men and one woman within the untreated group and two men and two women within the treated group indicated that they had such problems (22-5'1.). Those aware of a smell problem before testing had lower UPSIT test scores than those who were Unaware. also in accord with our earlier findings (respective means ( 
Discussion
Our results show that the olfactory deficit observed in early PO is not secondary to the use of anti-Parkinsonian drugs and. for a given subject, is relatively similar on both sides of the nose. Although modest asymmetries were present in the test scores of some of the PD patients, no relation was observ~d between the direction or magnitude of such asymmetries and the side of the motor dysfunction ofhemiParkinsonism. Importantly, the median olfactory asymmetry value of the PD patients was zero and the range of asymmetry values fell within that observed for normal subjects, As in the case of several other disorders in which olfaction is impair~d,)1 PD-related olfactory dysfunction was found to be less in women than in men. The basis of the olfactory dysfunction of PD is unknown, although it could reflect a PD-related vulnerability of the olfactory syst~m to destruction by ~nvironmental factors or PD-related retrograde degen~rative process~s. Several theorists have proposed that some forms of Parkinsonism and other neurodegenrative disorders, such as Alzheimer's disease, may be caused by th~ entry of environmental agents or toxins from the nasal cavity into the brain.)8 ,. The entry of viruses from the nasal cavity into the CNS is a well documented phenomenon,-and several large macromolecules can readily enter the CNS of rodents and other animals from the nos~.4S-48 PO may be associated with a breakdown of the mucosal barrier which normally detoxifies xenobiotic agents and prevents them from damaging the olfactory membrane or from entering into the CNS via the olfactory receptors or surrounding mucosal tissu~.4. G~nnane to this notion are observations that nasal tissues contain very high concentrations of enzymes that metabolise xenobiotics (for example, cytochromes P-450, flavin containing monooxygenase and aldehyde dehyrogenases, and carboxylesterases);.'2 metabolic rates for xenobiotics within nasal tissue typically exued those of other extrahepatic tissues and commonly exce~d those of the liver;'J and PO patients are less lik~ly to detoxify drugs by sulphation or sulphoxidation than are similarly exposed controls.w Whatever the basis for the olfactory dysfunction in PO, our patients showed average total UPSIT scores (L plus R UPSIT values) which, for all practical purposes, were equivalent to the bilateral UPSIT scores of PO patients reported in earlier work (respective means (SO) 21.95 (8'05) II 20.83 (7'44».' This is in spite of the fact that all but one of the present subj~cts wer~ at Hoehn and Yahr stage lor stage II of the disease process (compared to about half the subjects in the earlier study) and that nearly all had Parkinsonian symptoms for a inuch shorter period of time (respective symptom duration means in years (SO) 5'0 (3.3) II 12.4 (10-1». Whil~ these similarities are most likely a reflection of similar degrees of olfactory pathology within the two groups and the independence of the UPSIT scores from disease stage and duration, tWo factors may have had som~ differential influence on the test scores-Firstly, our patients were nearly five years younger than those in the earlier study and UPSIT scores are known to decline several points over this age period.n II Secondly, bilateral UPSIT testing, on average, tends to result in slightly higher UPSIT scores than unilatcral testing (for 
